Related Experiment Videos
Childhood Hodgkin's disease in Israel. A study of 17 cases
Insights
This study on pediatric Hodgkin's disease (H.D.) found that tailored radiotherapy and chemotherapy regimens led to long-term remission in most young patients. Early-stage H.D. responded well to radiation, while advanced stages required combined chemotherapy.
Area of Science:
- Pediatric Oncology
- Hematology
- Clinical Research
Background:
- Hodgkin's disease (H.D.) presents unique ethnic distributions, notably in Arab and Oriental Jewish children.
- A higher incidence of mixed cellularity histology is observed in Arab children with H.D.
Purpose of the Study:
- To evaluate the efficacy of different therapeutic approaches for pediatric Hodgkin's disease based on histological subtype and disease stage.
- To analyze survival rates and remission periods in response to varied treatment protocols.
Main Methods:
- Retrospective analysis of 17 pediatric Hodgkin's disease cases.
- Treatment strategies included extended field regional radiotherapy, combined chemotherapy (chlorambucil, vinblastine, MOPP), and multi-agent chemotherapy (MOPP).
- Therapeutic regimens were tailored to H.D. histological subtypes (lymphocyte predominance, nodular sclerosis, mixed cellularity) and clinical stages (IA, IIA, IIIA, IIIB, IV).
Main Results:
- Conservative radiotherapy alone achieved long first complete remission in early-stage (IA, IIA) lymphocyte predominance and nodular sclerosis H.D.
- Advanced stages (IIIB, IV) treated with six cycles of chemotherapy (chlorambucil/vinblastine or MOPP) showed positive outcomes.
- Four cycles of MOPP post-radiotherapy improved outcomes for mixed cellularity H.D. Stage IIA and Stage IIIA.
Conclusions:
- Specific radiotherapy and chemotherapy protocols demonstrate significant efficacy in treating pediatric Hodgkin's disease.
- Adherence to tailored treatment schedules is crucial for achieving long-term remission and survival in pediatric H.D. patients.
- The study highlights the importance of individualized treatment based on histology and stage for improved pediatric Hodgkin's disease outcomes.
Abstract:
A study of 17 children suffering from Hodgkin's disease (H.D.) is presented. The special ethnic distribution with predominance in Arab and Oriental Jewish children is noted. A high incidence of mixed cellularity histology in Arab children is emphasized. A conservative approach to therapy, i.e. extended field regional radiotherapy only, resulted in a long first complete remission period in lymphocyte predominance and nodular sclerosis H.D. Stages IA and IIA. All children in Stage IIIB and IV were treated by six courses of combined chemotherapy, and were maintained either on chlorambucil and vinblastine or on MOPP. Patients with mixed cellularity H.D. Stage IIA and all patients in Stage IIIA were treated by four courses of MOPP after the completion of extended regional radiotherapy. The 5 children who did not receive the schedules treatment died. The remaining 12 are well, with a survival of 8 to 104 months.